Daiwa Securities Group Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 167 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$37
-30.2%
38,7350.0%0.00%
Q2 2023$53
-13.1%
38,7350.0%0.00%
Q1 2023$61
-74.6%
38,7350.0%0.00%
-100.0%
Q4 2022$240
-99.9%
38,735
-39.9%
0.00%
-50.0%
Q3 2022$432,000
+5.6%
64,4350.0%0.00%
+33.3%
Q2 2022$409,000
-1.9%
64,435
-28.4%
0.00%0.0%
Q1 2022$417,000
+19.1%
90,052
+28.6%
0.00%
+50.0%
Q4 2021$350,000
+34900.0%
70,052
+134615.4%
0.00%
Q3 2021$1,0000.0%520.0%0.00%
Q2 2021$1,0000.0%520.0%0.00%
Q1 2021$1,0000.0%520.0%0.00%
Q4 2020$1,000
-83.3%
52
-66.2%
0.00%
Q3 2020$6,000
+20.0%
1540.0%0.00%
Q2 2020$5,0000.0%1540.0%0.00%
Q1 2020$5,000
-44.4%
1540.0%0.00%
Q4 2019$9,000
+50.0%
154
-9.9%
0.00%
Q3 2019$6,000
-25.0%
1710.0%0.00%
Q2 2019$8,000
+14.3%
1710.0%0.00%
Q1 2019$7,0000.0%171
+17.9%
0.00%
Q4 2018$7,000
+16.7%
1450.0%0.00%
Q3 2018$6,0000.0%1450.0%0.00%
Q2 2018$6,000
-40.0%
1450.0%0.00%
Q1 2018$10,0001450.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders